Itamar Medical Inc.
60 State Street
Suite 700
Boston
Massachusetts
02109
United States
Tel: 617-878-2161 or 888-7-ITAMAR
Fax: 617-371-2950
Website: http://www.itamar-medical.com/
Email: info@itamar-medical.com
23 articles about Itamar Medical Inc.
-
Israel-Based Itamar Medical Inc. Picks Atlanta for North American HQ, to Create 30+ New Jobs
12/5/2016
-
FDA Clears Expanded Indication For Itamar Medical Inc.'s WatchPAT Sleep Apnea Diagnostic Device For Adolescents
7/27/2016
-
New Agreement Puts Itamar Medical Inc. And Arterial Health International On Track To Offer Greater Access To Innovative Cardiovascular Testing In The United States
4/20/2015
-
Itamar Medical Inc.: Yelin Lapidot And Migdal Insurance To Invest NIS 23.6 Million In Private Equity Placement
5/8/2014
-
Itamar Medical Inc. Inks Distribution Deals With Medtronic, Inc., Philips Healthcare
3/19/2014
-
Itamar Medical Inc. Announced Today That the American Medical Association Has Awarded a CPT Category III Code to a Test Performed by Its EndoPATTM Proprietary Device
7/8/2013
-
Itamar Medical Inc. Taps New CEO
5/20/2013
-
Itamar Medical Inc. Launches Next-Generation, Cardiovascular Health Assessment Platform
3/22/2012
-
Roche and Itamar Medical Inc. Move Forward in Developing EndoPAT™ for Pre-Clinical Longitudinal Studies
1/4/2012
-
Itamar Medical Inc. Products Receive Brazilian ANVISA Certification to Enter South American Market
12/13/2011
-
Henry Schein, Inc. Selects Itamar Medical Inc.'s WatchPAT™ as Integral Part of Their New Dental Sleep Program
11/29/2011
-
Itamar Medical Inc. and Roche Sign Agreement For EndoPAT(TM) Devices in Pre-Clinical Drug Development
12/20/2010
-
You Can Now 'Watch' Yourself for Sleep Apnea, Itamar Medical Inc. Study
10/26/2010
-
Itamar Medical Inc.'s WatchPAT(TM) Spearheads Breakthrough Of At-Home Testing For Sufferers Of Sleep Apnea
10/5/2010
-
Itamar Medical Inc. EndoPAT(TM) at the Center of Assessing Cardiovascular Risk
3/23/2010
-
Itamar Medical Inc. and Roche Sign Agreement for EndoPAT Devices in Drug Development Study
3/16/2010
-
Japanese Government Grants SHONIN to Itamar Medical Inc.'s EndoPAT(TM) Device
7/20/2009
-
Itamar Medical Inc. Release: Study Shows that Flavonoid Supplements Prevent Impairment of Endothelial Function After High-Fat Meals
2/18/2009
-
Itamar Medical Inc.'s Endo-PAT2000 Approved For Use by Australian Government's TGA
12/15/2008
-
BioMarin Pharmaceutical Inc. Uses Itamar Medical Inc.'s Endo-PAT2000 In Successful Phase 2 Study For New Treatment For Sickle Cell Disease
12/5/2008